These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2931024)

  • 1. The effect of serotonergic blockade in postpartum preeclamptic patients.
    Montenegro R; Knuppel RA; Shah D; O'Brien WF
    Am J Obstet Gynecol; 1985 Sep; 153(2):130-4. PubMed ID: 2931024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapartum treatment of preeclamptic hypertension by ketanserin--a serotonin receptor antagonist.
    Weiner CP; Gelfan R; Socol ML
    Am J Obstet Gynecol; 1984 Jul; 149(5):576-8. PubMed ID: 6742030
    [No Abstract]   [Full Text] [Related]  

  • 4. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J; Koehle W; Gruebel B; Fisher R
    J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm.
    De Caterina R; Carpeggiani C; L'Abbate A
    Circulation; 1984 May; 69(5):889-94. PubMed ID: 6705164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapartum treatment of preeclamptic hypertension by ketanserin.
    Hulme VA; Odendaal HJ
    Am J Obstet Gynecol; 1986 Aug; 155(2):260-3. PubMed ID: 2943161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.
    Steyn DW; Odendaal HJ
    Lancet; 1997 Nov; 350(9087):1267-71. PubMed ID: 9357405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin.
    Steyn DW; Odendaal HJ
    Obstet Gynecol Surv; 2000 Sep; 55(9):582-9. PubMed ID: 10975485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication.
    Bounameaux H; Holditch T; Hellemans H; Berent A; Verhaeghe R
    Lancet; 1985 Dec; 2(8467):1268-71. PubMed ID: 2866336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketanserin in the acute management of severe hypertension.
    Murphy BF; Whitworth JA; Kincaid-Smith P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S168-71. PubMed ID: 2412044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.
    van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH
    Microcirc Endothelium Lymphatics; 1985; 2(6):657-85. PubMed ID: 2942753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of antagonist of S2-receptors.
    Petkovská N; Brimichová G; Tison P; Dzúrik R
    Czech Med; 1984; 7(4):210-4. PubMed ID: 6084584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin.
    Dzúrik R; Fetkovská N; Brimichová G; Tison P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S29-31. PubMed ID: 2412052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies with ketanserin in hypertension.
    Waal-Manning HJ; Brown SA; Spears GF; Simpson FO
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S154-8. PubMed ID: 2412040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketanserin in acute superficial thrombophlebitis.
    de Roose J; Symoens J
    Lancet; 1982 Aug; 2(8295):440-1. PubMed ID: 6124830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.